Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nurix Therapeutics, Inc. - Common stock (NQ:NRIX)

11.19 -0.90 (-7.44%)
Streaming Delayed Price Updated: 2:13 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 427,216
Open 12.17
Bid (Size) 11.16 (2)
Ask (Size) 11.20 (1)
Prev. Close 12.09
Today's Range 11.18 - 12.31
52wk Range 8.180 - 29.56
Shares Outstanding 47,147,781
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Which stocks are moving after the closing bell on Thursday?
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill

Performance

YTD
-42.6%
-42.6%
1 Month
-1.8%
-1.8%
3 Month
+9.3%
+9.3%
6 Month
-42.6%
-42.6%
1 Year
-48.6%
-48.6%

More News

Read More
A Glimpse Into The Expert Outlook On Nurix Therapeutics Through 5 Analysts
Via Benzinga
Amazon To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
8 Analysts Have This To Say About Nurix Therapeutics
Via Benzinga
Decoding 9 Analyst Evaluations For Nurix Therapeutics
Via Benzinga
The Analyst Verdict: Nurix Therapeutics In The Eyes Of 10 Experts
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why WK Kellogg Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Nurix Therapeutics Posts Better-Than-Expected Q2 Results; Revenue Soars on Sanofi and Gilead Payments
Via Stocktwits
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Unveiling 6 Analyst Insights On Nurix Therapeutics
Via Benzinga
Analyst Ratings For Nurix Therapeutics
Via Benzinga
What's going on in today's after hours session
Via Chartmill
Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout
Via Benzinga
Breaking Down Nurix Therapeutics: 7 Analysts Share Their Views
Via Benzinga
Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbs
Via Benzinga
Expert Outlook: Nurix Therapeutics Through The Eyes Of 9 Analysts
Via Benzinga
Beyond The Numbers: 8 Analysts Discuss Nurix Therapeutics Stock
Via Benzinga
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Via Benzinga
Topics ETFs Stocks
Wells Fargo To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Boeing, Nurix Therapeutics And 3 Stocks To Watch Heading Into Monday
Via Benzinga
This Amazon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Nvidia’s Earnings Loom In The Summer Stock Snooze-Fest
Via Talk Markets

Frequently Asked Questions

Is Nurix Therapeutics, Inc. - Common stock publicly traded?
Yes, Nurix Therapeutics, Inc. - Common stock is publicly traded.
What exchange does Nurix Therapeutics, Inc. - Common stock trade on?
Nurix Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nurix Therapeutics, Inc. - Common stock?
The ticker symbol for Nurix Therapeutics, Inc. - Common stock is NRIX on the Nasdaq Stock Market
What is the current price of Nurix Therapeutics, Inc. - Common stock?
The current price of Nurix Therapeutics, Inc. - Common stock is 11.19
When was Nurix Therapeutics, Inc. - Common stock last traded?
The last trade of Nurix Therapeutics, Inc. - Common stock was at 07/18/25 02:13 PM ET
What is the market capitalization of Nurix Therapeutics, Inc. - Common stock?
The market capitalization of Nurix Therapeutics, Inc. - Common stock is 527.58M
How many shares of Nurix Therapeutics, Inc. - Common stock are outstanding?
Nurix Therapeutics, Inc. - Common stock has 528M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.